Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Overman

Showing results (151-160 of 265) with videos related to

Pageof 27
Sort By:
Plos One|June 19, 2013
Gene expression profiling of ampullary carcinomas classifies ampullary carcinomas into biliary-like and intestinal-like subtypes that are prognostic of outcomeMichael J Overman, Jiexin Zhang, Scott Kopetz, et al.
The Oncologist|March 23, 2026
A retrospective analysis of taxane-based chemotherapy in small bowel adenocarcinomaMir Lim, Nikhil Grandhi, Preksha Shah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2018
DNA Sequencing of Small Bowel Adenocarcinomas Identifies Targetable Recurrent Mutations in the ERBB2 Signaling PathwayLiana Adam, F Anthony San Lucas, Richard Fowler, et al.
The Oncologist|August 10, 2022
Antibiotic Exposure Does Not Impact Immune Checkpoint Blockade Response in MSI-H/dMMR Metastatic Colorectal Cancer: A Single-Center ExperienceVictoria Serpas Higbie, Jane Rogers, Hyunsoo Hwang, et al.
Annals of Surgical Oncology|August 24, 2017
Utility of Appendiceal Calcifications Detected on Computed Tomography as a Predictor for an Underlying Appendiceal Epithelial NeoplasmTara L Sagebiel, Amr Mohamed, Aurelio Matamoros, et al.
British Journal of Cancer|August 14, 2019
Signet ring cell colorectal cancer: genomic insights into a rare subpopulation of colorectal adenocarcinomaKrittiya Korphaisarn, Van Morris, Jenifer S Davis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2023
Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: ASCO Endorsement of College of American Pathologists GuidelinePraveen Vikas, Hans Messersmith, Carolyn Compton, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 19, 2018
Evaluating for Pseudoprogression in Colorectal and Pancreatic Tumors Treated With ImmunotherapyChristine M Parseghian, Madhavi Patnana, Priya Bhosale, et al.
Oncotarget|July 16, 2016
MET amplification in metastatic colorectal cancer: an acquired response to EGFR inhibition, not a de novo phenomenonKanwal Raghav, Van Morris, Chad Tang, et al.
Langenbeck'S Archives of Surgery|February 28, 2023
Prognostic significance of acellular mucin in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) for appendiceal neoplasmsDerek J Erstad, Kristen A Robinson, Karen Beaty, et al.
Pageof 27

Showing results (151-160 of 265) with videos related to

Sort By:
Pageof 27
Plos One|June 19, 2013
Gene expression profiling of ampullary carcinomas classifies ampullary carcinomas into biliary-like and intestinal-like subtypes that are prognostic of outcomeMichael J Overman, Jiexin Zhang, Scott Kopetz, et al.
The Oncologist|March 23, 2026
A retrospective analysis of taxane-based chemotherapy in small bowel adenocarcinomaMir Lim, Nikhil Grandhi, Preksha Shah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2018
DNA Sequencing of Small Bowel Adenocarcinomas Identifies Targetable Recurrent Mutations in the ERBB2 Signaling PathwayLiana Adam, F Anthony San Lucas, Richard Fowler, et al.
The Oncologist|August 10, 2022
Antibiotic Exposure Does Not Impact Immune Checkpoint Blockade Response in MSI-H/dMMR Metastatic Colorectal Cancer: A Single-Center ExperienceVictoria Serpas Higbie, Jane Rogers, Hyunsoo Hwang, et al.
Annals of Surgical Oncology|August 24, 2017
Utility of Appendiceal Calcifications Detected on Computed Tomography as a Predictor for an Underlying Appendiceal Epithelial NeoplasmTara L Sagebiel, Amr Mohamed, Aurelio Matamoros, et al.
British Journal of Cancer|August 14, 2019
Signet ring cell colorectal cancer: genomic insights into a rare subpopulation of colorectal adenocarcinomaKrittiya Korphaisarn, Van Morris, Jenifer S Davis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2023
Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: ASCO Endorsement of College of American Pathologists GuidelinePraveen Vikas, Hans Messersmith, Carolyn Compton, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 19, 2018
Evaluating for Pseudoprogression in Colorectal and Pancreatic Tumors Treated With ImmunotherapyChristine M Parseghian, Madhavi Patnana, Priya Bhosale, et al.
Oncotarget|July 16, 2016
MET amplification in metastatic colorectal cancer: an acquired response to EGFR inhibition, not a de novo phenomenonKanwal Raghav, Van Morris, Chad Tang, et al.
Langenbeck'S Archives of Surgery|February 28, 2023
Prognostic significance of acellular mucin in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) for appendiceal neoplasmsDerek J Erstad, Kristen A Robinson, Karen Beaty, et al.
Pageof 27